Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZTI-01 PK and Safety in Pediatric Subjects
NCT03709914Phase 1Recruiting
- Sponsor
- Nabriva Therapeutics plc
- Start
- May 2018
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of fosfomycin disodium in bacterial infection, sponsored by Nabriva Therapeutics plc. Started May 2018; status: recruiting.
02
Drugs
fosfomycin disodium
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03709914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03709914.